128 related articles for article (PubMed ID: 37774669)
1. Targeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment.
Mallick R; Bhowmik P; Duttaroy AK
Biomed Pharmacother; 2023 Nov; 167():115591. PubMed ID: 37774669
[TBL] [Abstract][Full Text] [Related]
2. Too complex to fail? Targeting fatty acid metabolism for cancer therapy.
Munir R; Lisec J; Swinnen JV; Zaidi N
Prog Lipid Res; 2022 Jan; 85():101143. PubMed ID: 34856213
[TBL] [Abstract][Full Text] [Related]
3. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fatty acid metabolism reduces human myeloma cells proliferation.
Tirado-Vélez JM; Joumady I; Sáez-Benito A; Cózar-Castellano I; Perdomo G
PLoS One; 2012; 7(9):e46484. PubMed ID: 23029529
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-CoA carboxylase 1 depletion suppresses de novo fatty acid synthesis and mitochondrial β-oxidation in castration-resistant prostate cancer cells.
Liu S; Lai J; Feng Y; Zhuo Y; Zhang H; Chen Y; Li J; Mei X; Zeng Y; Su J; Deng Y; Jiang F; Yang S; Tan H; Hon CT; Wei S; Han Z; Wang F; Zhong W
J Biol Chem; 2023 Jan; 299(1):102720. PubMed ID: 36410440
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of lipid metabolism alterations in Cancer stem cells.
Yi M; Li J; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Peng S; Li X; Xiong W; Li G; Xiang B
J Exp Clin Cancer Res; 2018 Jun; 37(1):118. PubMed ID: 29907133
[TBL] [Abstract][Full Text] [Related]
8. Caffeic Acid Expands Anti-Tumor Effect of Metformin in Human Metastatic Cervical Carcinoma HTB-34 Cells: Implications of AMPK Activation and Impairment of Fatty Acids De Novo Biosynthesis.
Tyszka-Czochara M; Konieczny P; Majka M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230778
[TBL] [Abstract][Full Text] [Related]
9. Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer.
Liu Q; Luo Q; Halim A; Song G
Cancer Lett; 2017 Aug; 401():39-45. PubMed ID: 28527945
[TBL] [Abstract][Full Text] [Related]
10. The Bactericidal Fatty Acid Mimetic 2CCA-1 Selectively Targets Pneumococcal Extracellular Polyunsaturated Fatty Acid Metabolism.
Reithuber E; Nannapaneni P; Rzhepishevska O; Lindgren AEG; Ilchenko O; Normark S; Almqvist F; Henriques-Normark B; Mellroth P
mBio; 2020 Dec; 11(6):. PubMed ID: 33323510
[No Abstract] [Full Text] [Related]
11. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
12. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
[TBL] [Abstract][Full Text] [Related]
13. MiR-3180 inhibits hepatocellular carcinoma growth and metastasis by targeting lipid synthesis and uptake.
Hong J; Liu J; Zhang Y; Ding L; Ye Q
Cancer Cell Int; 2023 Apr; 23(1):66. PubMed ID: 37041584
[TBL] [Abstract][Full Text] [Related]
14. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer.
Watt MJ; Clark AK; Selth LA; Haynes VR; Lister N; Rebello R; Porter LH; Niranjan B; Whitby ST; Lo J; Huang C; Schittenhelm RB; Anderson KE; Furic L; Wijayaratne PR; Matzaris M; Montgomery MK; Papargiris M; Norden S; Febbraio M; Risbridger GP; Frydenberg M; Nomura DK; Taylor RA
Sci Transl Med; 2019 Feb; 11(478):. PubMed ID: 30728288
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.
Senga S; Kobayashi N; Kawaguchi K; Ando A; Fujii H
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1057-1067. PubMed ID: 29906613
[TBL] [Abstract][Full Text] [Related]
16. The Pharmacological or Genetic Blockade of Endogenous
Grunt TW; Lemberger L; Colomer R; López Rodríguez ML; Wagner R
Front Oncol; 2021; 11():610885. PubMed ID: 33928023
[TBL] [Abstract][Full Text] [Related]
17. Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.
Aregger M; Lawson KA; Billmann M; Costanzo M; Tong AHY; Chan K; Rahman M; Brown KR; Ross C; Usaj M; Nedyalkova L; Sizova O; Habsid A; Pawling J; Lin ZY; Abdouni H; Wong CJ; Weiss A; Mero P; Dennis JW; Gingras AC; Myers CL; Andrews BJ; Boone C; Moffat J
Nat Metab; 2020 Jun; 2(6):499-513. PubMed ID: 32694731
[TBL] [Abstract][Full Text] [Related]
18. Multi-substrate Metabolic Tracing Reveals Marked Heterogeneity and Dependency on Fatty Acid Metabolism in Human Prostate Cancer.
Fidelito G; De Souza DP; Niranjan B; De Nardo W; Keerthikumar S; Brown K; Taylor RA; Watt MJ
Mol Cancer Res; 2023 Apr; 21(4):359-373. PubMed ID: 36574015
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives.
Irshad R; Tabassum S; Husain M
Curr Top Med Chem; 2023; 23(12):1090-1103. PubMed ID: 37218199
[TBL] [Abstract][Full Text] [Related]
20. Aberrant lipid metabolism as a therapeutic target in liver cancer.
Pope ED; Kimbrough EO; Vemireddy LP; Surapaneni PK; Copland JA; Mody K
Expert Opin Ther Targets; 2019 Jun; 23(6):473-483. PubMed ID: 31076001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
